Literature DB >> 21556951

Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population.

Andrew J Spillane1, Lauren Haydu, William McMillan, Jonathan R Stretch, John F Thompson.   

Abstract

BACKGROUND: Regional lymph node dissection (RLND) is currently the most effective therapy for metastatic melanoma in groin lymph nodes. With thorough surgery, RLND lymph node (LN) retrieval numbers have a predictable distribution. Whether patients have inguinal or ilioinguinal dissection varies between institutions. This study was designed to provide LN retrieval parameters for inguinal and ilioinguinal LN dissections, and secondarily, to analyze known predictors for survival outcomes, including LN ratio, i.e., involved/total number LN removed.
METHODS: A prospective database was used to identify 189 patients who had 200 groin dissections between July 2002 and February 2008 to derive parameters of LN retrieval. A subgroup of 177 patients who had one RLND was assessed for predictors of survival outcome.
RESULTS: Inguinal dissection had median LN retrieval of 11 (interquartile range, 10-14); 8 LN or more were retrieved in 90% of cases, and 38% of cases had 10 LN or less. Ilioinguinal dissection had median LN retrieval of 21.5 (interquartile range, 17-25); 14 LN or more were retrieved in 90% of cases, and 0 cases had 10 LN or less. The strongest predictors of survival on multivariate analysis were LN ratio, macroscopic LN disease, and ulceration of the primary melanoma. Overall 39% of ilioinguinal dissections had positive pelvic LNs, but only 9.3% of those completed after positive sentinel node biopsy.
CONCLUSIONS: Thorough groin RLNDs have a predictable LN yield. LN ratio is the strongest predictor of outcome. Because pelvic LNs are frequently positive ilioinguinal dissection should be considered for all patients, especially those with macroscopic metastases to groin LNs.

Entities:  

Mesh:

Year:  2011        PMID: 21556951     DOI: 10.1245/s10434-011-1755-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Robotic-Assisted Pelvic Lymphadenectomy for Metastatic Melanoma Results in Durable Oncologic Outcomes.

Authors:  John T Miura; Lesly A Dossett; Ram Thapa; Youngchul Kim; Aishwarya Potdar; Hala Daou; James Sun; Amod A Sarnaik; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2019-04-04       Impact factor: 5.344

2.  Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.

Authors:  James W Jakub; Alicia M Terando; Amod Sarnaik; Charlotte E Ariyan; Mark B Faries; Sabino Zani; Heather B Neuman; Nabil Wasif; Jeffrey M Farma; Bruce J Averbook; Karl Y Bilimoria; Travis E Grotz; Jacob B Jake Allred; Vera J Suman; Mary Sue Brady; Douglas Tyler; Jeffrey D Wayne; Heidi Nelson
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

3.  Lymph node retrieval rates in melanoma: a quality assessment parameter.

Authors:  D Berger-Richardson; E Cordeiro; M Ernjakovic; A M Easson
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

4.  Robotic-Assisted Transperitoneal Pelvic Lymphadenectomy for Metastatic Melanoma: Early Outcomes Compared with Open Pelvic Lymphadenectomy.

Authors:  Lesly A Dossett; Nicholas B Castner; Julio M Pow-Sang; Andrea M Abbott; Vernon K Sondak; Amod A Sarnaik; Jonathan S Zager
Journal:  J Am Coll Surg       Date:  2016-01-14       Impact factor: 6.113

5.  Laparoscopically assisted ilio-inguinal lymph node dissection versus inguinal lymph node dissection in melanoma.

Authors:  Enrique Boldo; Araceli Mayol; Rafael Lozoya; Alba Coret; Diana Escribano; Carlos Fortea; Andres Muñoz; Juan Carlos Pastor; Guillermo Perez De Lucia
Journal:  Melanoma Manag       Date:  2020-07-21

6.  Validation of the prognostic value of lymph node ratio in patients with penile squamous cell carcinoma: a population-based study.

Authors:  Yao Zhu; Cheng-Yuan Gu; Ding-Wei Ye
Journal:  Int Urol Nephrol       Date:  2013-07-23       Impact factor: 2.370

7.  Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin.

Authors:  D Verver; M F Madu; C M C Oude Ophuis; M Faut; J H W de Wilt; J J Bonenkamp; D J Grünhagen; A C J van Akkooi; C Verhoef; B L van Leeuwen
Journal:  Br J Surg       Date:  2017-11-02       Impact factor: 6.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.